Journal Neuronal Signaling

Aim & Scope

The mission of Neuronal Signaling is to provide an interdisciplinary home for neuroscience covering all aspects of in vitro and in vivo signaling from cell to brain in health and disease. Relevant topics range from signaling pathways involved in nervous system development and normal physiology through to neurodegenerative, neurological and psychiatric disorders and other pathologies. Neuronal Signaling is a peer-reviewed, open access journal and is a home for research and reviews on molecular and cellular neuroscience, supported by Editor-in-Chief Clare Stanford and an expert Editorial Board. Neuronal Signaling is published by Portland Press on behalf of the Biochemical Society. The Biochemical Society is the UK’s largest single-discipline learned society, promoting the advancement of molecular bioscience; Portland Press is the publishing arm of the Biochemical Society, with all profits being returned to the Society for them to carry out their charitable endeavours. The journal’s interdisciplinary scope includes (but is not limited to) basic signaling mechanisms (e.g. neurotransmitters, ions and ion channels, receptors and messenger molecules, molecular genetics and epigenetic mechanisms), as well as electrical signaling, signaling in neural circuits (including neuroimaging), signaling aspects of pathologies, synaptic transmission and plasticity, and therapeutic intervention. The Journal covers a number of areas of neuroscience, including (but not limited to): Addiction, affective disorders and depression, aging, cellular and molecular mechanisms of behaviour, cognition, epilepsy, gene therapy, learning and memory, neurodegeneration, neuroendocrinology, neurogenesis, neuroimmunology, neurooncology, neuropharmacology and therapeutics, neurotoxicity, pain and analgesia, psychiatric disorders, stress and fear, stroke and cerebrovascular disease, technical developments and methodologies in neuroscience research. ^[1]

Go to Website